Oxford Pharmascience Group (OXP)
OXP Share PerformanceMore
|52 week high||7.8900 20/05/16|
|52 week low||1.5000 30/12/16|
|52 week change||-3.0500 (-64.21%)|
|4 week volume||52,808,829 28/03/17|
Media for (OXP)
Latest News« previous» nextMore
31/03/2017 - 11:49 StockMarketWire
Weaker commodity prices hit miners with Anglo American (AAL), Antofagasta (ANTO) and BHP Billiton (BLT) falling b...
31/03/2017 - 09:05 RNS
RNS Number: 1522B Oxford Pharmascience Group PLC 31 March 2017 Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this security would still have executed more than a pre-d...
31/03/2017 - 09:02 StockMarketWire
London shares were a little lower in early deals with heavyweight miners providing decisive ballast, but Old Mutual took t...
31/03/2017 - 09:00 RNS
RNS Number: 1516B Oxford Pharmascience Group PLC 31 March 2017 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered in an individual security's auction call before ...
31/03/2017 - 07:44 StockMarketWire
Oxford Pharmascience Group said the US FDA has not agreed with the proposed phase III study design for the OXPzero Ib...
31/03/2017 - 07:00 RNS
RNS Number: 1026B Oxford Pharmascience Group PLC 31 March 2017 31 March 2017 Oxford Pharmascience Group plc ("Oxford Pharmascience" or the "Company") FDA Pre-IND Feedback on OXPzero Ibuprofen Rx programme Oxford Pharmascience Group plc (AIM: OXP), the speciality pharmaceutical company that redevelops medicines to make them better, s...
10/03/2017 - 08:36 StockMarketWire
Oxford Pharmascience has roughly halved its FY pretax loss to 1.9m, from a loss of 3.9m a year earlier. Revenues totalled 7...
10/03/2017 - 08:00 RNS
RNS Number: 0823Z Oxford Pharmascience Group PLC 10 March 2017 10 March 2017 Oxford Pharmascience Group plc ("Oxford Pharmascience" or the "Company") Final Results for the year ended 31 December 2016 Oxford Pharmascience Group plc (AIM: OXP), the speciality pharmaceutical company that redevelops medicines to make them better, safer and easie...
|Dividend yield||0 %|
Latest discussion posts More
“That seems logical, I will hold on in the HOPE it passes 2p and take a small profit, if not, leave for 2 or 3 years and most probably have this same conversation again.”▼
“I've bailed after a big hit! The way I read it, they have no product. If they want to release it as planned then they need more trials which could cost millions and also, ...”▼
“I have committed today at 1.7p, my first investment ever in anything outside the FT250. From my understanding of this sector, I don't expect much movement either up or down for ...”▼
Codes & Symbols
|Symbols||OXP, LSE:OXP, OXP.L, OXP:LN, LON:OXP, XLON:OXP|